Taro Pharmaceuticals U.S.A., Inc. 2022-01-19 Health critical FDA
Health · FDA · Recall #FDA-D-0375-2022
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro… Recall
Issued January 19, 2022 · Taro Pharmaceuticals U.S.A., Inc.
In January 2022, Taro Pharmaceuticals U.S.A., Inc. recalled the Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
What you should do
- 1 Stop using Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Taro Pharmaceuticals U.S.A., Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Health
- Recall date
- January 19, 2022
- Units affected
- Not reported
- Sold at
- Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
- Recall number
- FDA-D-0375-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Taro Pharmaceuticals U.S.A., Inc. has 1 recall in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.